The Board of Directors of GlaxoSmithKline plc (“GSK”), the majority shareholder of Galvani Bioelectronics (“Galvani”), today announced the termination of Moncef Slaoui as Chair of the Galvani Board of Directors, effective immediately.

The termination follows the receipt of a letter containing allegations of sexual harassment and inappropriate conduct towards an employee of GSK by Dr. Slaoui, which occurred several years ago when he was an employee of GSK.

— GSK

Sources:

• 
  March 24, 2021. “Moncef Slaoui Departs Galvani Bioelectronics Board of Directors.” GSK.
  https://www.gsk.com/en-gb/media/press-releases/moncef-slaoui-departs-galvani-bioelectronics-board-of-directors/.
  General Website Link.